Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003742375 | SCV004470269 | pathogenic | Chromosome 2q32-q33 deletion syndrome | 2023-05-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu494Glyfs*15) in the SATB2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SATB2 are known to be pathogenic (PMID: 25885067). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SATB2-related conditions. For these reasons, this variant has been classified as Pathogenic. |